{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:59:35Z","timestamp":1771919975948,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3947-x","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T09:07:39Z","timestamp":1555578459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Direct-acting antivirals and visceral leishmaniasis: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Claudia","family":"Colomba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Saporito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manlio","family":"Tolomeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Cervo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Firenze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Trizzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"3947_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijid.2012.12.024","volume":"17","author":"L Saporito","year":"2013","unstructured":"Saporito L, Giammanco GM, De Grazia S, et al. Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host. Int J Infect Dis. 2013;17:572\u20136.","journal-title":"Int J Infect Dis"},{"key":"3947_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-199","volume":"9","author":"C Colomba","year":"2009","unstructured":"Colomba C, Saporito L, Vitale F, Reale S, Vitale G, Casuccio A, Tolomeo M, Maranto D, Rubino R, Di Carlo P, Titone L. Cryptic Leishmania infantum infection in Italian HIV infected patients. BMC Infect Dis. 2009;9:199. https:\/\/doi.org\/10.1186\/1471-2334-9-199 .","journal-title":"BMC Infect Dis"},{"key":"3947_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/1120009X.2017.1323150","volume":"29","author":"P Pagliano","year":"2017","unstructured":"Pagliano P, Esposito S. Visceral leishmaniosis in immunocompromised host: an update and literature review. J Chemother. 2017;29:261\u20136.","journal-title":"J Chemother"},{"key":"3947_CR4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/135965350400900417","volume":"9","author":"M Puoti","year":"2004","unstructured":"Puoti M, Babudieri S, Rezza G, et al. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther. 2004;9:627\u201330.","journal-title":"Antivir Ther"},{"key":"3947_CR5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/135965350501000502","volume":"10","author":"A Cascio","year":"2005","unstructured":"Cascio A, Antinori S, Ricciardi F, Costantino G, Iaria C. Visceral leishmaniasis during pegylated interferon therapy for chronic hepatitis C: first report. Antivir Ther. 2005;10:695\u20136; author reply 696.","journal-title":"Antivir Ther"},{"issue":"1 Suppl","key":"3947_CR6","first-page":"11","volume":"20","author":"C F","year":"2016","unstructured":"F C, Di Marco V, RESIST - HCV. The HCV Sicily network: a web-based model for the management of HCV chronic liver diseases. Eur Rev Med Pharmacol Sci. 2016;20(1 Suppl):11\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3947_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1517\/13543784.2013.806482","volume":"22","author":"N Shah","year":"2013","unstructured":"Shah N, Pierce T, Kowdley KV. Review of direct acting antiviral agents for the treatment of chronic hepatitis C. Expert Opin Investig Drugs. 2013;22:1107\u201321.","journal-title":"Expert Opin Investig Drugs"},{"key":"3947_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1196\/annals.1307.018","volume":"1026","author":"F Vitale","year":"2004","unstructured":"Vitale F, Reale S, Vitale M, Petrotta E, Torina A, Caracappa S. TaqMan-based detection of Leishmania infantum DNA using canine samples. Ann N Y Acad Sci. 2004 Oct;1026:139\u201343.","journal-title":"Ann N Y Acad Sci"},{"key":"3947_CR9","first-page":"421","volume":"13","author":"S Grandhe","year":"2017","unstructured":"Grandhe S, Frenette CT. Occurrence and recurrence of hepatocellular carcinoma after successful direct-acting antiviral therapy for patients with chronic hepatitis C virus infection. Gastroenterol Hepatol (N Y). 2017;13:421\u20135.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"3947_CR10","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1172\/JCI75938","volume":"124","author":"EG Meissner","year":"2014","unstructured":"Meissner EG, Wu D, Osinusi A, et al. Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. J Clin Invest. 2014;124:3352\u201363.","journal-title":"J Clin Invest"},{"key":"3947_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S2468-1253(18)30002-5","volume":"3","author":"M M\u00fccke","year":"2018","unstructured":"M\u00fccke M, Backus LI, M\u00fccke VT, et al. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2018;3:172\u201380.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3947_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4254\/wjh.v9.i3.161","volume":"9","author":"MP Ballester-Ferr\u00e9","year":"2017","unstructured":"Ballester-Ferr\u00e9 MP, Mart\u00ednez F, Garcia-Gimeno N, Mora F, Serra MA. Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin. World J Hepatol. 2017;9:161\u20136.","journal-title":"World J Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3947-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3947-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3947-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T06:22:32Z","timestamp":1663309352000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3947-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,18]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3947"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3947-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,18]]},"assertion":[{"value":"14 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"328"}}